Assignee
CROSSIGNAL THERAPEUTICS INC
US·1 granted patent·1 pending application·0 citations·filing 2022–2023
Top patents by PatentIndex Score
2 records- 0157US12065444B2Substituted tetrazolo[1,5-a]pyrazines and tetrazolo[1,5-c]pyrimidines as adenosine receptor antagonistsCROSSIGNAL THERAPEUTICS INC·Filed 2022·Granted Aug 20, 2024·0 cites·18 claims
- 0249US2025214976A1Gpr35 modulators and uses thereofCROSSIGNAL THERAPEUTICS INC·Filed 2023·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when CROSSIGNAL THERAPEUTICS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →